Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection Dorothea M. Wunder, M.D., Jean Guibourdenche, Ph.D., Martin H. Birkhäuser, M.D., Nick A. Bersinger, Ph.D. Fertility and Sterility Volume 90, Issue 6, Pages 2203-2210 (December 2008) DOI: 10.1016/j.fertnstert.2007.10.078 Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions
Figure 1 AMH (top panels) and inhibin B (bottom panels) concentrations in the follicular fluid (left panels) and the serum on the day of oocyte retrieval (right panels) as a function of the outcome of the IVF treatment cycle. x = no transfer (fertilization or cleavage failure); ○ = implantation failure; • = biochemical pregnancy; ▪ = clinical pregnancy. Note the logarithmic scale and, for inhibin B, the difference in the units on the ordinate. Horizontal bars are medians. Fertility and Sterility 2008 90, 2203-2210DOI: (10.1016/j.fertnstert.2007.10.078) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions
Figure 2 Correlation between inhibin B and the cumulated embryo score, a measure for the morphological quality, in the 259 cycles with embryo transfer (all outcomes combined). Fertilization and cleavage failure cycles (n = 17, cumulated embryo score = 0) are not included. Fertility and Sterility 2008 90, 2203-2210DOI: (10.1016/j.fertnstert.2007.10.078) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions